IDEAYA Biosciences, Inc. (FRA:30J)
Germany · Delayed Price · Currency is EUR 30.60
-0.40 (-1.29%)
Last updated: Dec 1, 2025, 8:04 AM CET
IDEAYA Biosciences Revenue
IDEAYA Biosciences had revenue of $207.83M USD in the quarter ending September 30, 2025. In the year 2024, IDEAYA Biosciences had annual revenue of $7.00M, down -70.07%.
Revenue
$7.00M
Revenue Growth
-70.07%
P/S Ratio
14.13
Revenue / Employee
$53.44K
Employees
131
Market Cap
2.59B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.00M | -16.39M | -70.07% |
| Dec 31, 2023 | 23.39M | -27.55M | -54.08% |
| Dec 31, 2022 | 50.93M | 22.99M | 82.28% |
| Dec 31, 2021 | 27.94M | 8.40M | 43.01% |
| Dec 31, 2020 | 19.54M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |